Major Players - Neuroendocrine Tumors Treatment Industry

Jul, 2023 - by CMI

Major Players - Neuroendocrine Tumors Treatment Industry

Cancer therapies vary. Targeted neuroendocrine tumor treatment is popular. Targeted cancer treatment works. Thus, tailored NET treatments will become more popular throughout the forecast period, driving market expansion. Somatostatins can treat certain pituitary tumors, but regulatory authorization for NET will stimulate its use in conjunction with specific therapies. Pasireotide is another somatostatin analogue being studied for NET. Chronic illness treatment is best using somatostain analogs. Avastin, a monoclonal antibody, is being tested for carcinoid tumor therapy. Netazepide, a gastrin/CCK2 receptor antagonist, shrinks stomach carcinoid tumors in high-gastrin patients. As a rare condition, regulatory authorities prioritize fast-track and orphan drug classification for therapeutic proposals.

The global Neuroendocrine Tumors Treatment Market is estimated to be valued at US$ 1,448.1 million in 2019 and is expected to exhibit a CAGR of 10.6% during the forecast period (2019-2027).

Prominent Players in the Neuroendocrine Tumors Treatment Industry:

1. Pfizer Inc,

Pfizer Inc. was launch in 1849. And its headquarter - New York, New York, United States. It operate over 40 coutires. In 2019· Pfizer's Sutent and Novartis' Afinitor and Lutathera are all approved to treat certain neuroendocrine tumors, but no one drug can cover all

2. Novartis AG.

Novartis AG founded in 1996, and its Headquarters located in  Basel, Switzerland. The company operates in 30 Countries. In 2018 · Novartis to acquire Advanced Accelerator Applications pending outcome of tender offer and works council consultation.

3. Ispen

Ispen was launch in 1994 and it’s headquarter located Paris, France.it operate over 100 country.

 4. Advanced Accelerator Applications

Advanced Accelerator Applications was launch in 2002 and it’s headquarter Rhone-Alpes, France ..it operate over 100 country.

5. Tarveda Therapeutics

Tarveda Therapeutics, was founded 2011, with its headquarters in Massachusetts, United States..With businesses in over 100 countries.

6. Progenics Pharmaceuticals

Progenics Pharmaceuticals was launch in 1986. And its headquarter New York City USA. It operate over 95 country.

7. Hutchison Medipharma Limited

Hutchison Medipharma Limited Founded in 2002 and it’s headquarter located Shanghai, China, It operate over 80 country.

*Definition- Influencer marketing platforms are online solutions that are specially designed to help brands with their influencer marketing campaigns

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.